Skip to main content
. 2021 Mar 15;12(10):2855–2865. doi: 10.7150/jca.52282

Figure 2.

Figure 2

Global burden of cirrhosis and liver cancer due to NASH by age in 2017. (A) Prevalence number of cirrhosis due to NASH; (B) DALYs number of cirrhosis due to NASH; (C) Prevalence number of liver cancer due to NASH; (B) DALYs number of liver cancer due to NASH. NASH: nonalcoholic steatohepatitis; DALYs: disability-adjusted life years.